Phage Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.phagepharma.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Safety Study of Topical Human FGF-1 for Wound Healing
Phase 1
- Conditions
- Diabetic Foot Ulcers
- Interventions
- Drug: FGF-1 141
- First Posted Date
- 2009-06-09
- Last Posted Date
- 2012-03-12
- Lead Sponsor
- Phage Pharmaceuticals, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT00916292
- Locations
- 🇺🇸
Dedicated Phase I, Phoenix, Arizona, United States
Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency
Phase 1
Completed
- Conditions
- Growth Hormone Deficiency
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2012-03-12
- Lead Sponsor
- Phage Pharmaceuticals, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT00489294
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
News
No news found